Cite
HARVARD Citation
Kwak, S. et al. (2020). Comparison of the effects of gemigliptin and dapagliflozin on glycaemic variability in type 2 diabetes: A randomized, open‐label, active‐controlled, 12‐week study (STABLE II study). Diabetes, obesity & metabolism. 22 (2), pp. 173-181. [Online].